These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 19519446)
1. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Hanai H; Sugimoto K Curr Pharm Des; 2009; 15(18):2087-94. PubMed ID: 19519446 [TBL] [Abstract][Full Text] [Related]
2. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Baliga MS; Joseph N; Venkataranganna MV; Saxena A; Ponemone V; Fayad R Food Funct; 2012 Nov; 3(11):1109-17. PubMed ID: 22833299 [TBL] [Abstract][Full Text] [Related]
3. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Wang Y; Tang Q; Duan P; Yang L Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):476-482. PubMed ID: 30111198 [TBL] [Abstract][Full Text] [Related]
4. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases? Mazieiro R; Frizon RR; Barbalho SM; Goulart RA J Med Food; 2018 Nov; 21(11):1077-1085. PubMed ID: 29957091 [TBL] [Abstract][Full Text] [Related]
5. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Ukil A; Maity S; Karmakar S; Datta N; Vedasiromoni JR; Das PK Br J Pharmacol; 2003 May; 139(2):209-18. PubMed ID: 12770926 [TBL] [Abstract][Full Text] [Related]
6. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. Vecchi Brumatti L; Marcuzzi A; Tricarico PM; Zanin V; Girardelli M; Bianco AM Molecules; 2014 Dec; 19(12):21127-53. PubMed ID: 25521115 [TBL] [Abstract][Full Text] [Related]
7. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease. Sardou HS; Vosough PR; Abbaspour M; Akhgari A; Sathyapalan T; Sahebkar A Inflammopharmacology; 2023 Jun; 31(3):1095-1105. PubMed ID: 36757584 [TBL] [Abstract][Full Text] [Related]
8. [Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases]. Blázovics A; Hagymási K; Prónai L Orv Hetil; 2004 Dec; 145(50):2523-9. PubMed ID: 15662752 [TBL] [Abstract][Full Text] [Related]
9. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Karthikeyan A; Young KN; Moniruzzaman M; Beyene AM; Do K; Kalaiselvi S; Min T Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918207 [TBL] [Abstract][Full Text] [Related]
10. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. Meng ZW; Chang B; Sang LX World J Gastroenterol; 2024 Jan; 30(3):280-282. PubMed ID: 38314128 [TBL] [Abstract][Full Text] [Related]
12. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Camacho-Barquero L; Villegas I; Sánchez-Calvo JM; Talero E; Sánchez-Fidalgo S; Motilva V; Alarcón de la Lastra C Int Immunopharmacol; 2007 Mar; 7(3):333-42. PubMed ID: 17276891 [TBL] [Abstract][Full Text] [Related]
13. Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice. Mouzaoui S; Rahim I; Djerdjouri B Int Immunopharmacol; 2012 Jan; 12(1):302-11. PubMed ID: 22036766 [TBL] [Abstract][Full Text] [Related]
14. Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-κB signal transduction pathways in rats with ulcerative colitis. Sakthivel KM; Guruvayoorappan C Int Immunopharmacol; 2013 Nov; 17(3):907-16. PubMed ID: 24126114 [TBL] [Abstract][Full Text] [Related]
15. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials. Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice. Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. V VP; C G Int Immunopharmacol; 2014 Jan; 18(1):124-34. PubMed ID: 24269623 [TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Effects of Fargesin on Chemically Induced Inflammatory Bowel Disease in Mice. Yue B; Ren YJ; Zhang JJ; Luo XP; Yu ZL; Ren GY; Sun AN; Deng C; Wang ZT; Dou W Molecules; 2018 Jun; 23(6):. PubMed ID: 29880739 [TBL] [Abstract][Full Text] [Related]
19. Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice. Sudirman S; Hsu YH; He JL; Kong ZL PLoS One; 2018; 13(10):e0205252. PubMed ID: 30289911 [TBL] [Abstract][Full Text] [Related]
20. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B. Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]